» Articles » PMID: 30857519

Gene and Environmental Interactions According to the Components of Lifestyle Modifications in Hypertension Guidelines

Overview
Date 2019 Mar 13
PMID 30857519
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Risk factors for hypertension consist of lifestyle and genetic factors. Family history and twin studies have yielded heritability estimates of BP in the range of 34-67%. The most recent paper of BP GWAS has explained about 20% of the population variation of BP. An overestimation of heritability may have occurred in twin studies due to violations of shared environment assumptions, poor phenotyping practices in control cohorts, failure to account for epistasis, gene-gene and gene-environment interactions, and other non-genetic sources of phenotype modulation that are suspected to lead to underestimations of heritability in GWAS. The recommendations of hypertension guidelines in major countries consist of the following elements: weight reduction, a healthy diet, dietary sodium reduction, increasing physical activity, quitting smoking, and moderate alcohol consumption. The hypertension guidelines are mostly the same for each country or region, beyond race and culture. In this review, we summarize gene-environmental interactions associated with hypertension by describing lifestyle modifications according to the hypertension guidelines. In the era of precision medicine, clinicians who are responsible for hypertension management should consider the gene-environment interactions along with the appropriate lifestyle components toward the prevention and treatment of hypertension. We briefly reviewed the interaction of genetic and environmental factors along the constituent elements of hypertension guidelines, but a sufficient amount of evidence has not yet accumulated, and the results of genetic factors often differed in each study.

Citing Articles

Global, regional, and national disease burden attributable to high systolic blood pressure in youth and young adults: 2021 Global Burden of Disease Study analysis.

He C, Lu S, Yu H, Sun Y, Zhang X BMC Med. 2025; 23(1):74.

PMID: 39915840 PMC: 11804021. DOI: 10.1186/s12916-025-03918-1.


Genome-Wide Approach of Gene-Nutrient Intake Interaction Study for Essential Hypertension in a Large Korean Cohort (KoGES).

Song Y, Choi J, Park J, Kwon Y, Hong K, Lee J Nutrients. 2024; 16(23).

PMID: 39683541 PMC: 11644644. DOI: 10.3390/nu16234147.


The effects of kiwifruit consumption on anthropometric and cardiometabolic indices in adults: A systematic review and meta-analysis.

Pam P, Goudarzi M, Ghotboddin Mohammadi S, Asbaghi O, Aghakhani L, Clark C Food Sci Nutr. 2024; 12(10):7017-7032.

PMID: 39479621 PMC: 11521643. DOI: 10.1002/fsn3.4385.


Metabolic Dysfunction-Associated Steatotic Liver Disease in Japan: Prevalence Trends and Clinical Background in the 10 Years before the Coronavirus Disease 2019 Pandemic.

Sato A, Oomori Y, Nakano R, Matsuura T Medicina (Kaunas). 2024; 60(8).

PMID: 39202611 PMC: 11356294. DOI: 10.3390/medicina60081330.


Mechanisms of inflammation modulation by different immune cells in hypertensive nephropathy.

Hao X, Liu Y, Hailaiti D, Gong Y, Zhang X, Yue B Front Immunol. 2024; 15:1333170.

PMID: 38545112 PMC: 10965702. DOI: 10.3389/fimmu.2024.1333170.


References
1.
Iso H, Harada S, Shimamoto T, Sato S, Kitamura A, Sankai T . Angiotensinogen T174M and M235T variants, sodium intake and hypertension among non-drinking, lean Japanese men and women. J Hypertens. 2000; 18(9):1197-206. DOI: 10.1097/00004872-200018090-00005. View

2.
Sacks F, Svetkey L, Vollmer W, Appel L, Bray G, Harsha D . Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N Engl J Med. 2001; 344(1):3-10. DOI: 10.1056/NEJM200101043440101. View

3.
Moore T, Conlin P, Ard J, Svetkey L . DASH (Dietary Approaches to Stop Hypertension) diet is effective treatment for stage 1 isolated systolic hypertension. Hypertension. 2001; 38(2):155-8. DOI: 10.1161/01.hyp.38.2.155. View

4.
Takagi S, Baba S, Iwai N, Fukuda M, Katsuya T, Higaki J . The aldehyde dehydrogenase 2 gene is a risk factor for hypertension in Japanese but does not alter the sensitivity to pressor effects of alcohol: the Suita study. Hypertens Res. 2001; 24(4):365-70. DOI: 10.1291/hypres.24.365. View

5.
Cuevas P, Carceller F, Gimenez-Gallego G . Fibroblast growth factors in myocardial ischemia / reperfusion injury and ischemic preconditioning. J Cell Mol Med. 2002; 5(2):132-42. PMC: 6517810. DOI: 10.1111/j.1582-4934.2001.tb00146.x. View